Embryonic Retinoid Concentrations after Maternal Intake of Isotretinoin
- 27 July 1989
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 321 (4) , 262
- https://doi.org/10.1056/nejm198907273210414
Abstract
To the Editor: The high risk of major malformation or spontaneous abortion in humans associated with fetal exposure to isotretinoin (Accutane, or 13-cis-retinoic acid) was well documented in 1985 by Lammer et al. in the Journal.1 Earlier experiments in mice demonstrated that the all-trans form of retinoic acid (tretinoin, or Retin-A) was highly teratogenic, and the 13-cis form only marginally so.2 Not until 1986, when precise measurements with use of high–performance liquid chromatography detected embryonic retinoid concentrations, was an answer for this discrepancy found. It was shown that in mice, the all-trans form of . . .Keywords
This publication has 5 references indexed in Scilit:
- Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: Comparison to the all-trans isomerToxicology and Applied Pharmacology, 1987
- Retinoic Acid EmbryopathyNew England Journal of Medicine, 1985
- Comparative teratogenic activities of two retinoids: Effects on palate and limb developmentTeratogenesis, Carcinogenesis, and Mutagenesis, 1984
- Pharmacokinetics of isotretinoin during repetitive dosing to patientsEuropean Journal of Clinical Pharmacology, 1983